Oren Pasvolsky, MD^1,2,3*, Denái R Milton, MS^4*, Mikael Rauf^1*, Sassine Ghanem, MD^1,5*, Adeel Masood^1*, Ali H Mohamedi^1*, Mark R Tanner, PhD^1*, Qaiser Bashir, MD¹, Samer A Srour, MD, MS¹, Neeraj Saini, MD¹, Paul Lin, MD, PhD¹, Jeremy L. Ramdial, MD¹, Yago Nieto, MD¹, Guilin Tang, MD, PhD^6*, Hans C. Lee, MD⁷, Krina Patel, MD, MSc⁷, Partow Kebriaei, MD¹, Sheeba K Thomas, MD⁷, Donna M. Weber, MD⁷, Robert Z. Orlowski, MD, PhD⁸, Katy Rezvani, MD¹, Elizabeth J Shpall, MD¹, Richard E Champlin, MD¹, Pei Lin, MD, DM, MDPC⁶ and Muzaffar H Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel
³Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Medicine, Alpert Medical School of Brown University, Providence, RI
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Christian Straka, M.D.¹, Kerstin Schaefer-Eckart, M.D.², Bernd Hertenstein, MD^3*, Florian Bassermann^4*, Hans Salwender, M.D.^5*, Christian Langer, M.D.^6*, Jan Krönke^7*, Miriam Kull, MD^8*, Georgia Schilling, M.D.^9*, Aneta Schieferdecker, M.D.^10*, Monika Engelhardt, M.D.¹¹, Stefan Knop, M.D.^12*, Julia Reusch, M.D.^13*, Wolf Roesler, M.D.^14*, Bernd Metzner, M.D.¹⁵, Holger Hebart, M.D.¹⁶, Albrecht Reichle, M.D.^17*, Matthias Grube, M.D.^17*, Norbert Frickhofen, M.D.¹⁸, Christian Gerecke, M.D.^19*, Stephan Fuhrmann, M.D.^20*, Wolfram Jung, M.D.^21*, Martin Gramatzki, M.D.²², Thomas Decker, M.D.^23*, Tobias Dechow, M.D.^23*, Jochen Greiner, M.D.^24*, Tim H. Brümmendorf, MD²⁵, Juliana Ababei, M.D.^26*, Ivana von Metzler, MD^27*, Ralph Naumann, MD²⁸, Elisabeth Fritz, M.D.^29*, Marcus Hentrich, M.D.^30*, Peter Bojko, M.D.^30*, Thomas Kubin, M.D.^31*, Christian Schmidt, M.D.^32*, Martin Kaufmann, MD³³, Burkhard Schmidt, M.D.^34*, Axel Hinke, Ph.D.^35* and Hermann Einsele, MD³⁶

¹Clinic of Hematology, Oncology and Stem Cell Transplantation, Muenchen Klinik Schwabing, Munich, Germany
²Klinikum Nuernberg, Nuernberg, Germany
³Klinikum Bremen Mitte, Bremen, Germany
⁴Department of Medicine III, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany
⁵Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany
⁶Kempten Clinic, Kempten, Germany
⁷Ulm University Hospital, Ulm, Germany
⁸Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
⁹UKE, Hamburg, Germany
¹⁰University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹¹Department of Medicine I Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
¹²University Clinic Würzburg, Wuerzburg, Germany
¹³Muenster University Hospital, Muenster, Germany
¹⁴Med. Klinik III / Poliklinik, Universitätsklinik Erlangen, Erlangen, Germany
¹⁵Klinikum Oldenburg, Oldenburg, Germany
¹⁶Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany
¹⁷University Hospital Regensburg, Regensburg, Germany
¹⁸HSK Wiesbaden, Wiesbaden, Germany
¹⁹Helios Hospital Berlin Buch, Berlin, Germany
²⁰Helios Klinikum Berlin-Buch, Berlin, Germany
²¹Universitätsklinikum Göttingen, Göttingen, Germany
²²University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
²³Onkologie Ravensburg, Ravensburg, Germany
²⁴Diakonie Hospital Stuttgart, Stuttgart, Germany
²⁵Uniklinik RWTH Aachen, Aachen, Germany
²⁶Klinikum Landshut, Landshut, Germany
²⁷University Hospital Frankfurt, Frankfurt, Germany
²⁸Department for Internal Medicine 3, St. Marien-Krankenhaus Siegen, Siegen, Germany
²⁹Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
³⁰Red Cross Hospital Munich, Munich, Germany
³¹Klinikum Traunstein, Kliniken Südostbayern, Traunstein, Germany
³²University Greifswald, Greifswald, Germany
³³Medical Centre, Robert-Bosch-Hospital,, Stuttgart, Germany
³⁴Hämatologisch-Onkologische Gemeinschaftspraxis Pasing, Munich, Germany
³⁵CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany
³⁶Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany

Julie Cote, MD¹, Richard Leblanc, MD, FRCPC², Michael P. Chu^3*, Arleigh McCurdy, MD, BSc⁴, Esther Masih-Khan^5,6*, Moustafa Kardjadj, PhD^7*, Victor H Jimenez-Zepeda^8*, Kevin Song, MD, FRCPC⁹, Martha L Louzada, MD, MSc¹⁰, Hira S Mian, MD, MSc¹¹, Darrell White, MD^12*, Michael Sebag, MD, PhD¹³, Anthony Reiman, MD^14*, Julie Stakiw, MD, FRCPC¹⁵, Rami Kotb, MD, FRCPC¹⁶, Debra Bergstrom^17*, Muhammad Aslam, MD^18*, Rayan Kaedbey, MD¹⁹, Christopher P. Venner, MD²⁰, Engin Gul, BSc, MBA^21* and Donna E. Reece, MD, FRCPC²²

¹Hôpital de l'Enfant-Jésus, Division of Hematology and Medical Oncology, CHU de Québec - Université Laval, Quebec, QC, Canada
²Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
³Department of Oncology, Cross Cancer Institute, Edmonton, Alberta, Edmonton, AB, Canada
⁴Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
⁵Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Canadian Myeloma Research Group, Vaughan, Ontario, Canada, Vaughan, ON, Canada
⁷Canadian Myeloma Research Group, Toronto, ON, Canada
⁸Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada, Calgary, AB, Canada
⁹Division of Hematology, University of British Columbia and Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
¹⁰University of Western Ontario, London Health Sciences Centre, London, ON, Canada
¹¹Juravinski Cancer Centre (Hamilton-CCO), Hamilton, ON, Canada
¹²Division of Hematology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹³Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹⁴Oncology, Saint John Regional Hospital, Saint John, NB, CAN
¹⁵Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁶Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
¹⁷Division of Hematology, Memorial University of Newfoundland, St John’s, Newfoundland and Labrador, Canada, St John's, NF, Canada
¹⁸Allan Blair Cancer Center, Regina, SK, Canada
¹⁹Jewish General Hospital, McGill University, Montreal, QC, Canada
²⁰Lymphoma and Myeloma Program, BC Cancer, Vancouver Centre, Vancouver, BC, Canada
²¹Canadian Myeloma Research Group (CMRG), Concord, ON, Canada
²²Princess Margaret Cancer Centre, Toronto, ON, Canada

Maria-Victoria Mateos, MD¹, Joaquín Martínez-López, MD, PhD^2*, Paula Rodríguez-Otero, MD, PhD^3*, Jesús San-Miguel, MD, PhD⁴, Veronica Gonzalez-Calle, MD, PhD^1*, Marta Sonia Gonzalez, MD^5*, Albert Oriol, MD^6*, Norma C. Gutierrez^1*, Rafael Rios, MD, PhD^7*, Laura Rosinol Dachs^8*, Miguel Angel Alvarez, MD^9*, Joan Bargay, MD, PhD^10*, Ana Pilar Gonzalez, PhD^11*, Fernando Escalante, MD^12*, Adrian Alegre, MD, PhD¹³, Belén Iñigo, MD^14*, Javier de la Rubia, MD^15*, Ana Isabel Teruel, MD^16*, Felipe De Arriba, PhD^17*, Luis Palomera, MD, PhD^18*, Miguel-Teodoro Hernández, MD, PhD^19*, Javier Lopez Jimenez, MD, PhD^20*, Marta Reinoso Segura^21*, Aránzazu García Mateo, PhD^22*, Enrique M. Ocio¹, Joan Bladé, MD, PhD^8*, Juan-José Lahuerta, MD, PhD^23*, María Teresa Cedena, MD, PhD^24*, Noemi Puig, MD, PhD²⁵ and Bruno Paiva^26*

¹Hospital Universitario de Salamanca,Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
²Department of Hematology, Hospital Universitario 12 de Octubre; Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre i+12,H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain
³Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain
⁴Clínica Universidad de Navarra, CCUN, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC, Pamplona, Spain
⁵Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, Spain
⁶Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
⁷Hospital Universitario Virgen de las Nieves de Granada, Instituto de Investigación Biosanitaria IBS GRANADA, Granada, Spain
⁸Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⁹Hospital Universitario Reina Sofia, Cordoba, Spain
¹⁰Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
¹¹Hospital Central de Asturias, Oviedo, Spain
¹²Hematology Department, Hospital Universitario de León, León, Spain
¹³Univeritary Hospital La Princesa, Madrid, Madrid, Spain
¹⁴Hematology, Hospital Universitario Clínico San Carlos, Madrid, Spain
¹⁵Hematology Department, University Hospital La Fe, Valencia, Spain
¹⁶Hospital Clínico Universitario de Valencia, VALENCIA, ESP
¹⁷Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
¹⁸Hospital Clínico U. "Lozano Blesa". Instituto Investigación Sanitaria Aragón, Zaragoza, Spain
¹⁹Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain
²⁰Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
²¹Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
²²Hospital General de Segovia, Segovia, Spain
²³Hospital Universitario 12 de Octubre; Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre i+12,H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain
²⁴Hospital Universitario 12 de Octubre, CNIO, Madrid, Spain
²⁵Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
²⁶Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain

Smita Bhatia, MD, MPH¹, Chengcheng Yan, MD^2*, Melissa A Richard, PhD^3*, Jianbo He, MD⁴, Alysia Bosworth, BA^5*, David Crossman^6*, Purnima Singh, PhD, MSc⁷, Lindsey Hageman, MPH^1*, Saro H. Armenian, DO, MPH⁸, Julie M. Vose, MD, MBA⁹, Daniel J. Weisdorf, MD¹⁰, Yutaka Yasui, PhD^11*, Benjamin L. Ebert, MD, PhD¹², Christopher J. Gibson, MD¹³, Stephen J Forman, MD¹⁴ and Ravi Bhatia, MD^15,16

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²University of Alabama at Birmingham, Birmingham, AL
³The University of Texas Health Science Center at Houston, Houston, TX
⁴Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁵Department of Population Sciences, City of Hope, Durate, CA
⁶Genomics Core Facility, University of Alabama at Birmingham, Birmingham, AL
⁷Children's of Alabama Hospital, Birmingham, AL
⁸Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA
⁹Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center - Fred and Pamela Buffett Cancer Center, Omaha, NE
¹⁰Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
¹¹Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
¹²Dana-Farber Cancer Institute, Boston, MA
¹³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁴Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
¹⁵Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
¹⁶Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham

Hussein Awada^1*, Carmelo Gurnari, MD^1,2, Valeria Visconte, PhD¹, Teodora Kuzmanovic, BA^1*, Hassan Awada, MD^3*, James R. Cook, MD, PhD⁴, David S. Bosler, MD^4*, Brian J. Bolwell, MD⁵, Ronald M. Sobecks, MD⁵, Matt Kalaycio, MD⁵ and Jaroslaw P. Maciejewski, MD, PhD, FACP¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
³Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH
⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH